Figure 1.
Figure 1. Dose and time response of KIT and phosphorylated KIT protein to 17-AAG in HMC-1.1 and HMC-1.2 cells. (A) Mast cells were incubated with increasing concentrations of 17-AAG for 8 hours, and levels of KIT protein (i-ii), phosphorylated KIT protein (iii-iv), and tubulin (v-vi) were measured as described in “Patients, materials, and methods.” (B) Mast cells were incubated for increasing time intervals with 1 μM 17-AAG and levels of KIT protein (i-ii), phosphorylated KIT protein (iii-iv), and tubulin (v-vi) were measured as described in “Patients, materials, and methods.” Tubulin protein was measured to confirm that equal amounts of total protein were added in each lane.

Dose and time response of KIT and phosphorylated KIT protein to 17-AAG in HMC-1.1 and HMC-1.2 cells. (A) Mast cells were incubated with increasing concentrations of 17-AAG for 8 hours, and levels of KIT protein (i-ii), phosphorylated KIT protein (iii-iv), and tubulin (v-vi) were measured as described in “Patients, materials, and methods.” (B) Mast cells were incubated for increasing time intervals with 1 μM 17-AAG and levels of KIT protein (i-ii), phosphorylated KIT protein (iii-iv), and tubulin (v-vi) were measured as described in “Patients, materials, and methods.” Tubulin protein was measured to confirm that equal amounts of total protein were added in each lane.

Close Modal

or Create an Account

Close Modal
Close Modal